These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20305783)

  • 21. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.
    Sampson JH; Choi BD; Sanchez-Perez L; Suryadevara CM; Snyder DJ; Flores CT; Schmittling RJ; Nair SK; Reap EA; Norberg PK; Herndon JE; Kuan CT; Morgan RA; Rosenberg SA; Johnson LA
    Clin Cancer Res; 2014 Feb; 20(4):972-84. PubMed ID: 24352643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radioimmunoscintigraphy of intracranial glioma xenograft with a technetium-99m-labeled mouse monoclonal antibody specifically recognizing type III mutant epidermal growth factor receptor.
    Takasu S; Takahashi T; Okamoto S; Oriuchi N; Nakayashiki N; Okamoto K; Muramatsu H; Hayashi T; Nakahara N; Mizuno M; Wakabayashi T; Higuchi T; Endo K; Kozaki K; Miyaishi O; Saga S; Ueda R; Yoshida J; Yoshikawa K
    J Neurooncol; 2003 Jul; 63(3):247-56. PubMed ID: 12892230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel bispecific immunotoxin delivered by human bone marrow-derived mesenchymal stem cells to target blood vessels and vasculogenic mimicry of malignant gliomas.
    Zhang Y; Sun X; Huang M; Ke Y; Wang J; Liu X
    Drug Des Devel Ther; 2015; 9():2947-59. PubMed ID: 26089644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma.
    Ryu CH; Park KY; Kim SM; Jeong CH; Woo JS; Hou Y; Jeun SS
    Biochem Biophys Res Commun; 2012 May; 421(3):585-90. PubMed ID: 22525671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal.
    Lee HK; Finniss S; Cazacu S; Bucris E; Ziv-Av A; Xiang C; Bobbitt K; Rempel SA; Hasselbach L; Mikkelsen T; Slavin S; Brodie C
    Oncotarget; 2013 Feb; 4(2):346-61. PubMed ID: 23548312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
    Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
    J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 125I-labeled anti-epidermal growth factor receptor-vIII single-chain Fv exhibits specific and high-level targeting of glioma xenografts.
    Kuan CT; Reist CJ; Foulon CF; Lorimer IA; Archer G; Pegram CN; Pastan I; Zalutsky MR; Bigner DD
    Clin Cancer Res; 1999 Jun; 5(6):1539-49. PubMed ID: 10389943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human bone marrow-derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis.
    Ho IA; Toh HC; Ng WH; Teo YL; Guo CM; Hui KM; Lam PY
    Stem Cells; 2013 Jan; 31(1):146-55. PubMed ID: 23034897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFRvIII stimulates glioma growth and invasion through PKA-dependent serine phosphorylation of Dock180.
    Feng H; Hu B; Vuori K; Sarkaria JN; Furnari FB; Cavenee WK; Cheng SY
    Oncogene; 2014 May; 33(19):2504-12. PubMed ID: 23728337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.
    Sampson JH; Archer GE; Mitchell DA; Heimberger AB; Bigner DD
    Semin Immunol; 2008 Oct; 20(5):267-75. PubMed ID: 18539480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased in vivo angiogenic effect of glioma stromal mesenchymal stem-like cells on glioma cancer stem cells from patients with glioblastoma.
    Kong BH; Shin HD; Kim SH; Mok HS; Shim JK; Lee JH; Shin HJ; Huh YM; Kim EH; Park EK; Chang JH; Kim DS; Hong YK; Kim SH; Lee SJ; Kang SG
    Int J Oncol; 2013 May; 42(5):1754-62. PubMed ID: 23483121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.
    Yang W; Barth RF; Wu G; Ciesielski MJ; Fenstermaker RA; Moffat BA; Ross BD; Wikstrand CJ
    Clin Cancer Res; 2005 Jan; 11(1):341-50. PubMed ID: 15671565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMG 595, an Anti-EGFRvIII Antibody-Drug Conjugate, Induces Potent Antitumor Activity against EGFRvIII-Expressing Glioblastoma.
    Hamblett KJ; Kozlosky CJ; Siu S; Chang WS; Liu H; Foltz IN; Trueblood ES; Meininger D; Arora T; Twomey B; Vonderfecht SL; Chen Q; Hill JS; Fanslow WC
    Mol Cancer Ther; 2015 Jul; 14(7):1614-24. PubMed ID: 25931519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retrovirally engineered T-cell-based immunotherapy targeting type III variant epidermal growth factor receptor, a glioma-associated antigen.
    Ohno M; Natsume A; Ichiro Iwami K; Iwamizu H; Noritake K; Ito D; Toi Y; Ito M; Motomura K; Yoshida J; Yoshikawa K; Wakabayashi T
    Cancer Sci; 2010 Dec; 101(12):2518-24. PubMed ID: 20880333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A bivalent recombinant immunotoxin with high potency against tumors with EGFR and EGFRvIII expression.
    Meng J; Liu Y; Gao S; Lin S; Gu X; Pomper MG; Wang PC; Shan L
    Cancer Biol Ther; 2015; 16(12):1764-74. PubMed ID: 26467217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.
    Kuan CT; Wikstrand CJ; Archer G; Beers R; Pastan I; Zalutsky MR; Bigner DD
    Int J Cancer; 2000 Dec; 88(6):962-9. PubMed ID: 11093822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. hMSC-mediated concurrent delivery of endostatin and carboxylesterase to mouse xenografts suppresses glioma initiation and recurrence.
    Yin J; Kim JK; Moon JH; Beck S; Piao D; Jin X; Kim SH; Lim YC; Nam DH; You S; Kim H; Choi YJ
    Mol Ther; 2011 Jun; 19(6):1161-9. PubMed ID: 21386822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human marrow stromal cells secrete microRNA-375-containing exosomes to regulate glioma progression.
    Deng SZ; Lai MF; Li YP; Xu CH; Zhang HR; Kuang JG
    Cancer Gene Ther; 2020 Apr; 27(3-4):203-215. PubMed ID: 30728448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of mesenchymal stem cells as a vehicle to deliver replication-competent adenovirus for treating malignant glioma.
    Hai C; Jin YM; Jin WB; Han ZZ; Cui MN; Piao XZ; Shen XH; Zhang SN; Sun HH
    Chin J Cancer; 2012 May; 31(5):233-40. PubMed ID: 22429494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.